1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow Refractory Soft Tissue Sarcoma: new trials by email Literature Review of Refractory Soft Tissue Sarcoma trials Research Report on Refractory Soft Tissue Sarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas Itacitinib, Laboratory Biomarker Analysis - Metastatic Leiomyosarcoma, Metastatic Synovial Sarcoma | Phase 1 | Terminated | Fred Hutchinson Cancer Center | 27 | 2019-09-30 | 2024-05-08 |
Chondrosarcoma (1) · Histiocytoma, Malignant Fibrous (1) · Leiomyosarcoma (1) · Liposarcoma, Myxoid (1) · Sarcoma (1) · Sarcoma, Synovial (1)
Histiocytoma (1) · Liposarcoma (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Adipose Tissue (1) · Neoplasms, Connective Tissue (1) · Neoplasms, Connective and Soft Tissue (1) · Neoplasms, Fibrous Tissue (1) · Neoplasms, Muscle Tissue (1)
INCB039110 (1) · baricitinib (1) · itacitinib (1)
Fred Hutchinson Cancer Center (1)
United States (1)
Lee Cranmer (1)